ALDURAZYME (Genzyme Corporation)
Welcome to the PulseAid listing for the ALDURAZYME drug offered from Genzyme Corporation. This alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genzyme Corporation |
NON-PROPRIETARY NAME: | laronidase |
SUBSTANCE NAME: | LARONIDASE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2003-04-30 |
END MARKETING DATE: | 0000-00-00 |
ALDURAZYME HUMAN PRESCRIPTION DRUG Details:
Item Description | ALDURAZYME from Genzyme Corporation |
LABELER NAME: | Genzyme Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.9(mg/5mL) |
START MARKETING DATE: | 2003-04-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 58468-0070_fd3076d5-6e80-4457-9b59-8968630a3ad0 |
PRODUCT NDC: | 58468-0070 |
APPLICATION NUMBER: | BLA125058 |
Other LARONIDASE Pharmaceutical Manufacturers / Labelers: